<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Islets of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have the feature of an inflammatory process reflected by the presence of cytokines, immune cells, beta-cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, amyloid deposits and <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Indeed, beta-cells from patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> display inflammatory markers, including increased interleukin (IL)-1 beta expression </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, increased islet-associated macrophages are observed in human type 2 diabetic patients and in most animal models of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Importantly, increased numbers of macrophages are detectable very early in high fat-fed mice islets, before the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>These immune cells are most likely attracted by islet-derived chemokines, produced in response to metabolic stress, and under the control of IL-1 beta </plain></SENT>
<SENT sid="5" pm="."><plain>It follows that modulation of intra-islet <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, in particular IL-1 beta, may prevent <z:mp ids='MP_0004031'>insulitis</z:mp> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and therefore presents itself as a possible causal therapy with disease-modifying potential </plain></SENT>
</text></document>